Trends in Investigator-Initiated Clinical Studies at a University Hospital after Enforcement of the 2018 Clinical Trials Act in Japan
Yasutaka Sato(Tokushima University Hospital), Hiroaki Yanagawa(Tokushima University Hospital), Yuki Aoe(Tokushima University Hospital), Kenshi Takechi(Matsuyama University), Hiroshi Nokihara(Tokushima University Hospital), Hirofumi Hamano(Tokushima University Hospital), Chikako Kane(Tokushima University Hospital), Mitsuhiro Goda(Okayama University), Masayuki Chuma(Nihon University), Kenta Yagi(Tokushima University Hospital), Satoshi Sakaguchi(Tokushima University Hospital), Yoshiaki Kubo, Ichiro Hashimoto(Tokushima University)
Cited by 2
Related Papers
Association Between Immune-Related Adverse Events and Clinical Efficacy in Patients with Melanoma Treated With Nivolumab: A Multicenter Retrospective Study
|Clinical Therapeutics|2018|99
Randomized controlled trial of S-1 versus docetaxel in patients with non-small-cell lung cancer previously treated with platinum-based chemotherapy (East Asia S-1 Trial in Lung Cancer)
|Annals of Oncology|2017|97
Royal Jelly Ameliorates Insulin Resistance in Fructose-Drinking Rats
|Biological and Pharmaceutical Bulletin|2008|88
Efficacy and Safety of Ultrahigh-Dose Methylcobalamin in Early-Stage Amyotrophic Lateral Sclerosis
|JAMA Neurology|2022|85
Retrospective analysis of steroid therapy for radiation-induced lung injury in lung cancer patients
|Radiotherapy and Oncology|2006|68